- In Vitro and In Vivo Imaging of Prostate Cancer Angiogenesis Using Anti-Vascular Endothelial Growth Factor Receptor 2 Antibody-Conjugated Quantum Dot
-
Kwon H, Lee J, Song R, Hwang SI, Lee J, Kim YH, Lee HJ
- KMID: 1430041
- Korean J Radiol.
- 2013 Feb;14(1):30-37.
- doi: 10.3348/kjr.2013.14.1.30
OBJECTIVE: Authors aimed to determine the targeting ability of vascular endothelial growth factor receptor 2 (VEGFR2)-conjugated quantum dots (QDs) in vitro, and apply it for a xenograft prostate cancer mouse... -
- CITED
-
- Close
- SHARE
-
- Close
- Visualization of Tumor Angiogenesis Using MR Imaging Contrast Agent Gd-DTPA-anti-VEGF Receptor 2 Antibody Conjugate in a Mouse Tumor Model
-
Jun HY, Yin HH, Kim SH, Park SH, Kim HS, Yoon KH
- KMID: 984899
- Korean J Radiol.
- 2010 Aug;11(4):449-456.
- doi: 10.3348/kjr.2010.11.4.449
OBJECTIVE: To visualize tumor angiogenesis using the MRI contrast agent, Gd-DTPA-anti-VEGF receptor 2 antibody conjugate, with a 4.7-Tesla MRI instrument in a mouse model. MATERIALS AND METHODS: We designed a... -
- CITED
-
- Close
- SHARE
-
- Close
